Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

A NEW “game-changing” drug could stop the progression of Alzheimer’s disease, early trials suggest. Scientists say the treatment – called trontinemab – could be the ...

Vascular dementia, the second most prevalent form of dementia after Alzheimer's disease, affects approximately 180,000 people ...

It takes an average of 3.5 years to diagnose patients with dementia following their first symptoms, according to researchers.

Researchers say changes are particularly beneficial for carriers of a gene that may raise the risk of dementia ...

"Bleeds on the brain due to high blood pressure, or again, vessel damage. And all of these things, they interrupt the oxygen ...

A new drug could halt the progression of Alzheimer's disease - granting hope to thousands who suffer from the illness.

FORGETTING where you left your keys, struggling to recall names and dates… memory issues tend to be the most common signs of ...

New research has found that the build-up of proteins associated with Alzheimer's disease were reduced by a plant compound, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new Alzheimer’s drug has been hailed as a major breakthrough after clinical trials showed it could clear the harmful brain ...

Dementia UK is launching free clinics in Sutton and beyond this August, offering expert advice from Admiral Nurses on dementia-related concerns.